However, stomach problems were “significantly more common” among youngsters taking the drugs. Experts in the US carried out a review and meta-analysis of 18 trials involving GLP-1 agonists on ...

ENDO 2025 featured the latest research on novel therapies for adrenal and neuroendocrine conditions, new data on various ...

Over the last four years, weight-loss drugs that dampen down appetite and promote satiety have revolutionised obesity ...